Priority Date: 01.07.15 (US 201562187461P)

SUBSTITUTED QUINAZOLINE COMPOUNDS AND USES THEREOF FOR MODULATING GLUCOCEREBROSIDASE ACTIVITY

  • Application ID: EP16818810
  • Status: Request for examination was made

Applicant

Research organisation logo small
Research Organisation

Attorney

no operation time available
857.15
1 office
active in Legal Services

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 231 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 01.07.2015 - Priority Date (US 201562187461P)
  • 05.01.2017 - Publication A1 (WO2017004405)
  • 09.05.2018 - Publication A1 (EP3317265)